Starkova N T, Mel'nichenko G A
Probl Endokrinol (Mosk). 1978 Nov-Dec;24(6):42-7.
The results of use of rifathyroin (the Soviet preparation thyroliberin), a stimulant of prolactin secretion, and of L-DOPA and cholstylbegit, blockers of prolactin secretion, in patients with various forms of the persisting lactorrhea-amenorrhea syndrome are presented in this work. Reaction of rifathyroin proved to be disturbed in these patients, i.e. decreased in adenomas and hypothalamic disturbances and exceedingly increased in combination of primary hypothyroidism and lactorrhea. L-DOPA and chlostylbegit were capable of reducing prolactin level in patients with the persisting lactorrhea-amenorrhea syndrome, this being accompanied by restoration of biphasic menstrual cycle in some of the patients. The use of estrogens led to increase of the serum prolactin level. Problems of diagnostic value of the test with rifathyroin, and of the efficacy of various therapeutic methods applied in lactorrhea-amenorrhea are discussed.
本文介绍了使用催乳素分泌刺激剂利法甲状腺素(苏联制剂促甲状腺素释放激素)以及催乳素分泌阻滞剂左旋多巴和氯苯丁酯,对各种形式持续性溢乳-闭经综合征患者的治疗结果。在这些患者中,利法甲状腺素的反应受到干扰,即在腺瘤和下丘脑功能障碍时降低,而在原发性甲状腺功能减退合并溢乳时则极度升高。左旋多巴和氯苯丁酯能够降低持续性溢乳-闭经综合征患者的催乳素水平,部分患者的双相月经周期得以恢复。使用雌激素会导致血清催乳素水平升高。文中还讨论了利法甲状腺素试验的诊断价值以及应用于溢乳-闭经的各种治疗方法的疗效问题。